CClinicalTrials.gg
RecruitingNCT05383586Updated May 16, 2023

MusicHyperBrain Study With Preterm Infants and Their Parents

An interventional study of Creative Music Therapy in Pre-Term, sponsored by University of Zurich. Recruiting at 1 site in Switzerland. Open to participants aged 32 Weeks to 36 Weeks. Per ClinicalTrials.gov, last updated 2023-05-16.

Sponsored by University of Zurich · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2023, 2 years 9 months ago, but the record still lists the study as recruiting.
  • Started Nov 2022; still recruiting 3 years 11 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
32 Weeks to 36 Weeks
Sex
All
01

Study summary

Inter-personal brain coupling between preterm infants, their parents and a musician during Creative Music Therapy using functional near-infrared imaging (fNIRI) hyperscanning and systemic physiology measurements

Read the detailed description

Background Preterm infants represent a growing population in health care. Unfortunately, many infants suffer from neurodevelopmental impairments that persist into adolescence and adulthood. Besides other risk factors, auditory deprivation (e.g., the lack of exposure to regular intrauterine rhythms of the maternal heartbeat and the maternal voice), and the overwhelming stressful auditory environment of an intensive care unit may negatively impact brain maturation. Studies showed that infant-parent separation can impede the bidirectional development of physical, emotional, and psychological bonds between parents and their infants. Brain development is linked to nurturing social contact and early auditory experience, as demonstrated by human and animal studies. New studies showed, music is promoting neurobiological processes and neuronal learning in the human brain, which starts before birth.

Rationale Creative Music Therapy (CMT) provides meaningful interactions and a nurturing enrichment of the auditory environment by infant-directed singing in lullaby-style. Positive short-term music therapy outcomes (i.e., arousal, behavior, respiratory rate, maternal anxiety) have been shown in several reviews. Preliminary results of a recent pilot feasibility randomized controlled trial (RCT) suggest that functional brain connectivity as measured by resting-state functional magnet resonance imaging seems to have a possible early beneficial effect of CMT which manifests in (1) lower thalamo-cortical processing delay, (2) stronger functional networks, and (3) higher functional integration in predominantly left prefrontal, supplementary motor and inferior temporal brain regions. Depressive symptoms may be decreased and physical connectedness increased between infants and their parents with CMT. However, real time evaluation of CMT's possible immediate effect on the brain activity in infants and inter-personal synchronization processes between parents and infants have not been conducted yet.

The primary objective is to explore if CMT:

Improves inter-personal interaction between the infant, the parent (i.e. the mother or father) and the music therapist assessed via cerebral oxygenation synchronization between the infant and parent as well as the infant and the music therapist in the left auditory cortex and frontal cortex.

The secondary objectives are to explore if CMT:

  • synchronizes inter-personal emotional/ stress responses between infant, parents (and music therapist)
  • improves/ regulates brain activity in the infants' left auditory cortex and frontal cortex (evidenced by less fluctuations of cerebral hemodynamics and oxygenation)
  • reduces stress in the infants
  • reduces stress in the parents (mother or father)

Additionally, we aim to explore the parental perspective of CMT and their study participation.

Primary endpoint*:

Inter-personal synchronization of cerebral oxygenation and hemoglobin concentration in the brain between the infant and the parent as well as the infant and the music therapist measured by functional near-infrared spectroscopy (fNIRS) neuroimaging with a commercially available device approves for clinical applications (OxyPrem) in the left auditory and prefrontal cortex

Major secondary endpoints*:

  • Inter-personal synchronization/ coupling of systemic physiology (emotional/ stress responses) in the infant and the parent as well as in the infant and the music therapist measured by systemic physiological parameters (heart rate (HR), electrodermal activity (EDA), heart rate variability (HRV), respiration rate (RR))
  • Cerebral oxygenation activation/ regulation in the infant measured by fNIRS neuroimaging with OxyPrem in the left auditory and prefrontal cortex
  • Stress level in the infants measured by systemic parameters (HR, EDA, HRV)
  • Stress level in the parents measured by systemic parameters (EDA, HRV)
  • Parental perspective of CMT and study participation

    • 15 minutes before CMT (5 minutes without kangaroo/ 10 minutes in kangaroo), 20 minutes during kangaroo with CMT, and 10 minutes after CMT (10 minutes in kangaroo/ without kangaroo)/ first session of CMT during neonatal intensive care hospitalization in the second/third week after the preterm infant's birth

Intervention:

Once/second time 20 minutes CMT: entrained infant-directed live lullaby singing, accompanied with the vibro-acoustic monochord provided by the music therapist for infant and parents in kangaroo care as described in the published clinical practice protocol.

N= 20 infant-parent couples (effect size: 1.4; significance level: 0.05; power: 0.8)

Study duration:

  • Preparatory phase (months): 3 months
  • First patient to last patient in/recruitment/ intervention phase: 12 months
  • analysis: 2 months
  • Preparation publication: 3 months Duration of the entire trial (preparatory phase + study phase): 18 months

Statistical considerations:

Brain-to-brain coupling will be determined by coherence analysis based on the fNIRS signals measured. The time-dependent coherence changes will be analyzed statistically in order to see stat. significant changes during the task compared to the baseline. Synchronization of systemic physiological signals will be determined with the same approach. Statistical analysis will be performed with ANOVA and generalized additive models (GMAs).

02

Conditions studied

  • Pre-Term

Browse trials for

Keywords

  • music therapy
  • preterm infants
  • preterm parents
  • synchronization
  • hyperscanning
  • NIRS
  • HRV
  • oxyPrem
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's planned enrollment of 20 is below the median of 84 across 1,689 interventional studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

University of Zurich is the lead sponsor of 1,030 studies on the registry; 130 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
32 Weeks to 36 Weeks
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Clinically stable preterm infants (no invasive cardiovascular or ventilation support)
  • age: 7-21 days of life
  • born with 32 0/7 ≤ 36 6/7 weeks of gestation
  • mentally stable parents of the included infants

Exclusion criteria

Exclusion Criteria:

  • admission for palliative care
  • congenital malformation
  • parental psychiatric disorders
  • parental language barriers
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Creative Music Therapy

    20 minutes of infant-directed singing in lullaby-style accompanied with the monochord for preterm infant and parent during kangaroo-care

    Other: Creative Music Therapy

Interventions

  • OtherCreative Music Therapy

    Creative Music Therapy is provided during kangaroo-care. It is an individualized, family- centered approach offering infant-directed humming and singing accompanied with the monochord.

06

What researchers measure

Primary outcomes

  1. Inter-personal synchronization of cerebral oxygenation and hemoglobin concentration

    Inter-personal synchronization (determined by the time-dependent coherence calculated via Wavelet transform coherence) of cerebral oxygenation (StO2 in %) and total hemoglobin concentration (\[tHb\] in relative µM) time-series in the brain between the infant and the parent as well as the infant and the music therapist measured by functional near-infrared spectroscopy (fNIRS) neuroimaging with a commercially available device approves for clinical applications (OxyPrem) in the left auditory and prefrontal cortex. Both devices provide similar measurements of cerebral oxygenation and hemodynamics, i.e. relative changes in the concentration of oxyhemoglobin (\[O2Hb\] in relative µM) and deoxyhemoglobin (\[HHb\] in relative µM). These time-series will be first pre-processed (removal of artifacts, band-pass filtered (0.01-0.5 Hz)) and then analyzed (Wavelet coherence and subsequent statistical analysis via a generalized additive model and Bayesian analysis).

    Time frame: 50 minutes

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 16, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05383586
Lead sponsor
University of Zurich
Responsible party
Sponsor
First posted
May 20, 2022
Start date
Nov 3, 2022
Primary completion
Dec 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
May 16, 2023

Study contacts

Friederike Haslbeck, PhD
Contact
friederike.haslbeck@usz.ch
+41 78 708 1862
Felix Scholkmann, PD, PhD
Contact
felix.scholkmann@usz.ch
+41 44 255 53 45
Dirk Bassler, Prof.
study director · University Hospital Zurich, Department Neonatology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion